Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Transportation, E-Commerce & Mechanical Systems
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
GE HEALTHCARE Limited is currently navigating 5 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 5 actions are distributed among 5 distinct examiners, ensuring that each matter receives an individual assessment. The actions are spread across 4 distinct art units, which indicates that the company's biotech and pharmaceutical innovations are categorized into several different specialized divisions at the patent office.
ALDERSON, ANNE-MARIE K is the busiest examiner for the portfolio, currently managing 1 pending office action. Since there are 5 examiners for 5 actions, each examiner is responsible for exactly 1 matter. The distribution of 5 actions across 4 art units suggests a high degree of technical variety, as almost every pending action is being reviewed by a different specialized unit. For practitioners, this means managing 5 separate examiner relationships while adhering to the specific requirements of 4 different art units. This level of diversification requires a coordinated prosecution strategy to ensure that the company's biotech and pharmaceutical goals are met across these different specialized divisions. The company benefits from a variety of examiner perspectives while maintaining a focused presence in the biotechnology sector.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (25%) |
| Multi-statute (no §101) | 3 (75%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ALDERSON, ANNE-MARIE K | 1 | 32.4% | +40.8% |
| SCHLIENTZ, LEAH H | 1 | 41.9% | +38.5% |
| BRAZIN, JACQUELINE | 1 | 66.0% | +52.7% |
| CRAIG, KAILA ANGELIQUE | 1 | 33.8% | +25.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18569180 | METHOD FOR PREPARING AN [18F] RADIOLABELLED COMPOUND WITH LOW WATER CONTENT DURING LABELLING STEP | SCHLIENTZ, LEAH H | — |
| 18557528 | ANALYTICAL HPLC | BRAZIN, JACQUELINE | — |
| 17415842 | ULTRASOUND CONTRAST AGENT AND METHODS FOR USE THEREOF | CRAIG, KAILA ANGELIQUE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18859500 | MODEL GENERATION APPARATUS FOR THERAPEUTIC PREDICTION AND ASSOCIATED METHODS AND MODELS | ALDERSON, ANNE-MARIE K | 34d |
| 18569180 | METHOD FOR PREPARING AN [18F] RADIOLABELLED COMPOUND WITH LOW WATER CONTENT DURING LABELLING STEP | SCHLIENTZ, LEAH H | — |
| 18557528 | ANALYTICAL HPLC | BRAZIN, JACQUELINE | — |
| 17415842 | ULTRASOUND CONTRAST AGENT AND METHODS FOR USE THEREOF | CRAIG, KAILA ANGELIQUE | — |
| Art Unit | Apps |
|---|---|
| 1618 | 2 |
| 3682 | 1 |
| 1798 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18859500 | MODEL GENERATION APPARATUS FOR THERAPEUTIC PREDICTION AND ASSOCIATED METHODS AND MODELS | ALDERSON, ANNE-MARIE K | 3682 | §103 | Final Rejection | 34d | Pending | Oct 23, 2024 |
| 18569180 | METHOD FOR PREPARING AN [18F] RADIOLABELLED COMPOUND WITH LOW WATER CONTENT DURING LABELLING STEP | SCHLIENTZ, LEAH H | 1618 | §102§103§112 | Non-Final OA | — | Pending | Dec 11, 2023 |
| 18557528 | ANALYTICAL HPLC | BRAZIN, JACQUELINE | 1798 | §102§103 | Non-Final OA | — | Pending | Oct 26, 2023 |
| 17415842 | ULTRASOUND CONTRAST AGENT AND METHODS FOR USE THEREOF | CRAIG, KAILA ANGELIQUE | 1618 | §103§112 | Non-Final OA | — | Pending | Jun 18, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial